Explore more publications!
Indiana Healthcare Today
Got News to Share?

Indiana Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Indiana Healthcare Today.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on December 23, 2025

Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment
December 23, 2025

Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment

Indeterminate GlobeNewswire
Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA’s Qualification of Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation
December 23, 2025

Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA’s Qualification of Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation

Indeterminate GlobeNewswire
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test
December 23, 2025

Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test

Indeterminate GlobeNewswire
BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 23, 2025

BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
MannKind Shares FUROSCIX® Business Updates
December 23, 2025

MannKind Shares FUROSCIX® Business Updates

Indeterminate GlobeNewswire
Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease
December 23, 2025

Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease

Indeterminate GlobeNewswire
Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months
December 23, 2025

Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months

Indeterminate GlobeNewswire
Cassava Announces Agreement to Settle Securities Class Action Litigation
December 23, 2025

Cassava Announces Agreement to Settle Securities Class Action Litigation

Indeterminate GlobeNewswire
Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)
December 23, 2025

Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)

Indeterminate GlobeNewswire
Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia
December 23, 2025

Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia

Indeterminate GlobeNewswire
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial
December 23, 2025

LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial

Indeterminate GlobeNewswire
Join Jupiter Neurosciences’ Exclusive Live Investor Webinar and Q&A Session on January 6
December 23, 2025

Join Jupiter Neurosciences’ Exclusive Live Investor Webinar and Q&A Session on January 6

Indeterminate GlobeNewswire
Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th
December 23, 2025

Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th

Indeterminate GlobeNewswire
Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests 
December 23, 2025

Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests 

Indeterminate GlobeNewswire
Dyne Therapeutics Appoints Vikram Karnani to Board of Directors
December 23, 2025

Dyne Therapeutics Appoints Vikram Karnani to Board of Directors

Indeterminate GlobeNewswire
Avicanna Announces Changes to its Board of Directors
December 23, 2025

Avicanna Announces Changes to its Board of Directors

Indeterminate GlobeNewswire
Glucose Health, Inc. Completes Preferred Stock Conversion at an 85% Premium Positioning Company for Rapid Growth
December 23, 2025

Glucose Health, Inc. Completes Preferred Stock Conversion at an 85% Premium Positioning Company for Rapid Growth

Indeterminate GlobeNewswire
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
December 23, 2025

Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

Indeterminate GlobeNewswire
Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
December 23, 2025

Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

Indeterminate GlobeNewswire
LAPIX Therapeutics Announces First Patient Dosed in Phase Ib Study of LPX-TI641 in Atopic Dermatitis
December 23, 2025

LAPIX Therapeutics Announces First Patient Dosed in Phase Ib Study of LPX-TI641 in Atopic Dermatitis

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions